Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of Sep 26, 2014 06:05 PM ET

 Add to portfolio

$219.02 USD

+2.58 (1.19%)

Zacks MF Rank : 3 - Hold [?]     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Aug 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Aug 31, 2014) 20.45
Objective Health Care - Equity
Peer HL MG

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Hold 3
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 34.37
Net Assets (Mil $) 8/31/2014 8,218.95
%Turnover 8/31/2014 35.00

Allocation

% of Portfolio
Large Growth 31.24
Large Value 0.00
Small Growth 16.74
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 18.47
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 8/31/2014 % of Portfolio
Health 50.96
Services 27.34
Other 13.75
Industrial Cyclical 7.61
Technology 0.34

Portfolio Holdings

Top Equity Holdings
(As of 5/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 15.15 1,228.81
BIOGEN IDEC INC 7.09 574.73
AMGEN INC 6.04 489.73
~INTERCEPT PHARMACEUTICAL 3.39 275.08
VERTEX PHARMACEUTICALS IN 3.31 268.87
ALEXION PHARMACEUTICALS I 3.25 263.58
REGENERON PHARMACEUTICALS 3.19 258.64
INTERMUNE INC 2.58 209.46
CELGENE CORP 2.01 162.73

Stock Holding % of Net Assets

As Of 5/31/2014
Total Issues 187
Avg. P/E 42.86
Avg. P/Book 5.49
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 36,992

Risk

3 Year 5 Year 10 Year
Beta 0.92 1.04 0.80
Alpha 23.77 11.70 9.65
R Squared 0.24 0.40 0.34
Std. Dev. 21.55 21.65 20.26
Sharpe 2.19 1.49 2.00